Deutsche Bank’s Kite Pharma, Inc. KITE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-1,055
Closed -$109K 5274
2017
Q2
$109K Buy
+1,055
New +$86.1K ﹤0.01% 4180

Deutsche Bank's KITE Position: Q4 2017 in Review

Deutsche Bank sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 659,115 shares — an estimated $119M sold.

Deutsche Bank first reported a position in KITE in Q3 2014 and held it in 13 quarters. The position peaked at $119M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Deutsche Bank reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Deutsche Bank sold 659,115 Kite Pharma, Inc. shares in Q4 2017, an estimated $119M.
  • Deutsche Bank first reported a position in Kite Pharma, Inc. in Q3 2014 and held it in 13 quarters.
  • Deutsche Bank's Kite Pharma, Inc. position peaked at $119M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Deutsche Bank's 13F filing for Q4 2017, filed 14 Feb 2018.